Today @Univercells is proud to announce a new collaboration with @SerumInstIndia that will bring cutting-edge treatment options within reach of millions globally. Discover more on the partnership by reading our PR here: https://t.co/kCGv2s1gs2
Discover how Quantoom Biosciences, part of @Univercells_sa, is helping its partners to achieve low-cost, low-footprint, high-quality, and high-performance RNA production, from pre-clinical development to large-scale manufacturing.
Learn more by visiting https://t.co/lYNY5ylZUS
We are thrilled to announce that @Univercells_sa opened new offices in Andover, MA yesterday! Read the entire press release here: https://t.co/6EKcKnAJeC
@BultotH
Discover @BultotH's interview that was recently published in @pharmaboardroom (the global platform for healthcare & life sciences executives) on UNIVERCELLS Group's past, present and future developments: https://t.co/TVVPrmvR46
[PRESS RELEASE]
This collaboration among @EXOTHERA, LogicBio Therapeutics, and @Polyplus_Transf aims to develop a highly scalable and cost-effective AAV manufacturing platform! Read the press release: https://t.co/FG3JZuND59
#GeneTherapy#vaccines#AAVManufacturing
Press Release - Today we were honored to welcome Walloon Minister President Elio Di Rupo, Minister Borsus, Minister Morreale and the DGO6 delegation for a roadshow in three UNIVERCELLS affiliates. Read all of it here: https://t.co/TC7HSebI25
📢 Press Release - Univercells is pleased to announce the appointment of Timothy E. Morris as an independent director to its Board of Directors. Read all the details here: https://t.co/Zn181HPw9a
We are thrilled to announce the acquisition of @synHelix , a company with the mission of making an impact in synthetic biology, which faces a bottleneck in #DNA supply. #acquisition#globalhealth#syntheticbiology @AdventFrance
https://t.co/mIkqJOl8bI
📢 Welcome to Hala Audi, the new CEO of Unizima. Hala’s international background of more than 20 years, her cultural sensitivity and expertise, will enable her to lead the expansion of Unizima in 2022 with several exciting projects to come.” https://t.co/5uYngfScuL
Continuing our #investor activities in 2022, we are delighted to participate in the @KempenCo Life Sciences Virtual Crossover Conference taking place on January 6th. CEO Hugues Bultot and VP IR Alexandra Deschner will be available for one-on-one meetings. Join us !
Yesterday was the official launch of "Belgium, 'Health & Biotech valley' of the future". The event featured speeches from Alexander De Croo and Ursula von der Leyen. @BultotH, CEO of Univercells was part of the panel discussion: “Building the future”. https://t.co/KWF1886wdP
An innovative new partnership was announced to revolutionize access to COVID-19 and other vaccines in Africa. Read all of it here: https://t.co/wVFL6IM2nV
Today we provide European financing to boost innovative biotech company @Univercells_sa in deploying its COVID-19 vaccine manufacturing facility. Very pleased to sign with @BultotH and @IreneNorstedt a €30 million loan. #Horizon2020
Jose Castillo, CTO of Univercells, is participating in the World Local Production Forum organized by the @WHO . More info about the event: https://t.co/QVWwEBT2SV
#techtransfer#vaccines#biologicsforall
@BultotH , CEO d'#Univercells, revient sur les différents moments clés du Groupe depuis sa création en 2013, et plus spécialement sur le lancement de Quantoom Biosciences, une nouvelle filiale. Ne manquez pas l'interview diffusée au JT de la RTBF https://t.co/qc6JQZaVhT